1: Mussinu JM, Ruiu S, Mule AC, Pau A, Carai MA, Loriga G, Murineddu G, Pinna GA. Related Articles, Links
Tricyclic Pyrazoles. Part 1: Synthesis and Biological Evaluation of Novel 1,4-Dihydroindeno[1,2-c]pyrazol-based Ligands for CB(1)and CB(2 )Cannabinoid Receptors.
Bioorg Med Chem. 2003 Jan 17;11(2):251-63.
PMID: 12470719 [PubMed - in process]
2: Appendino G, Ligresti A, Minassi A, Daddario N, Bisogno T, Di Marzo V. Related Articles, Links
Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.
Bioorg Med Chem Lett. 2003 Jan 6;13(1):43-6.
PMID: 12467613 [PubMed - in process]
3: Begg M, Dale N, Llaudet E, Molleman A, Parsons ME. Related Articles, Links
Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum.
Br J Pharmacol. 2002 Dec;137(8):1298-304.
PMID: 12466239 [PubMed - in process]
4: Huffman JW, Bushell SM, Miller JR, Wiley JL, Martin BR. Related Articles, Links
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-Hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB(2) receptor.
Bioorg Med Chem. 2002 Dec;10(12):4119-29.
PMID: 12413866 [PubMed - in process]
5: Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK. Related Articles, Links
Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
J Pharmacol Exp Ther. 2002 Oct;303(1):314-22.
PMID: 12235266 [PubMed - indexed for MEDLINE]
Time used: 31 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005